Credit Suisse Group (CS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CS - US2254011081 - ADR
0.8858 USD
+0.01 (+0.99%)
0.899 USD
+0.01 (+1.49%)
We assign a fundamental rating of 1 out of 10 to CS. CS was compared to 235 industry peers in the Capital Markets industry. Both the profitability and financial health of CS have multiple concerns. CS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year CS has reported negative net income.
1.2 Ratios
- With a Return On Assets value of 1.00%, CS perfoms like the industry average, outperforming 48.02% of the companies in the same industry.
- CS has a Return On Equity of 10.01%. This is in the better half of the industry: CS outperforms 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1% | ||
| ROE | 10.01% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of CS (18.68%) is better than 64.85% of its industry peers.
- CS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 18.68% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for CS has been increased compared to 1 year ago.
- The debt/assets ratio for CS is higher compared to a year ago.
2.2 Solvency
- A Debt/Equity ratio of 2.80 is on the high side and indicates that CS has dependencies on debt financing.
- The Debt to Equity ratio of CS (2.80) is worse than 84.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.8 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
- CS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -702.95%.
- CS shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.34%.
- The Revenue has been decreasing by -6.52% on average over the past years.
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-576.1%
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y-6.52%
Sales Q2Q%318.56%
3.2 Future
- The Earnings Per Share is expected to grow by 16.46% on average over the next years. This is quite good.
- Based on estimates for the next years, CS will show a small growth in Revenue. The Revenue will grow by 2.57% on average per year.
EPS Next Y82.2%
EPS Next 2Y39.87%
EPS Next 3Y27.69%
EPS Next 5Y16.46%
Revenue Next Year-4.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y0.61%
Revenue Next 5Y2.57%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- CS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year CS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CS's earnings are expected to grow with 27.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.87%
EPS Next 3Y27.69%
5. Dividend
5.1 Amount
- CS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.8858
+0.01 (+0.99%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-24 2023-04-24/dmh
Earnings (Next)07-27 2023-07-27/bmo
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.50B
Revenue(TTM)28.98B
Net Income(TTM)5.41B
Analysts46.09
Price Target1.51 (70.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-126.63%
Min EPS beat(2)-230.24%
Max EPS beat(2)-23.02%
EPS beat(4)0
Avg EPS beat(4)-3226.79%
Min EPS beat(4)-11871.5%
Max EPS beat(4)-23.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)174.77%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)354.29%
Revenue beat(4)1
Avg Revenue beat(4)84.46%
Min Revenue beat(4)-9.84%
Max Revenue beat(4)354.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.18%
PT rev (3m)-56.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.11 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.06 | ||
| P/tB | 0.06 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.58
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.24
BVpS15.38
TBVpS14.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1% | ||
| ROE | 10.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 18.68% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.8 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)72.35%
Cap/Depr(5y)87.09%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-576.1%
EPS Next Y82.2%
EPS Next 2Y39.87%
EPS Next 3Y27.69%
EPS Next 5Y16.46%
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y-6.52%
Sales Q2Q%318.56%
Revenue Next Year-4.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y0.61%
Revenue Next 5Y2.57%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-8.83%
EBIT Next 3Y24.95%
EBIT Next 5YN/A
FCF growth 1Y-65.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.59%
OCF growth 3YN/A
OCF growth 5YN/A
Credit Suisse Group / CS FAQ
What is the ChartMill fundamental rating of Credit Suisse Group (CS) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CS.
What is the valuation status of Credit Suisse Group (CS) stock?
ChartMill assigns a valuation rating of 3 / 10 to Credit Suisse Group (CS). This can be considered as Overvalued.
What is the profitability of CS stock?
Credit Suisse Group (CS) has a profitability rating of 2 / 10.
Can you provide the financial health for CS stock?
The financial health rating of Credit Suisse Group (CS) is 0 / 10.